Learn about the ISN’s work in advocacy below.
The ISN Presents Evidence to the UK Committee on the Science of COVID-19
Professor Donal O’Donoghue, Chair of the ISN’s Advocacy Working Group, was among a distinguished panel of experts who gave evidence at the House of Lords Science and Technology Select Committee hearing on the Science of COVID-19 in the UK. Presenting at the beginning of the virtual session on Tuesday, September 15, Professor O’Donoghue outlined the...
ISN Teams up with DOPPS to Survey the Impact of COVID-19 on Dialysis Patients
The COVID-19 pandemic is likely to disproportionately impact people living with kidney disease. It is, therefore, more important than ever to monitor the care being delivered to patients with kidney diseases and to use data to advocate for those at risk of adverse outcomes. Recognizing this, the ISN has launched several data collection initiatives over the past few...
ASN/ERA-EDTA/ISN Joint Working Group’s Call to Action with Paper on Ethical Issues in Nephrology
Ethical challenges in nephrology: a call for action by the ASN/ERA-EDTA/ISN Joint Working Group on Ethical Issues in Nephrology, has been published in Nature Reviews Nephrology. The paper identifies ten broad areas of ethical concern as priority challenges that require collaborative action to highlight the need for ethical analysis of issues within kidney care and to...
The ISN Supports WHO’s Landmark Resolution at the World Health Assembly
On May 18, 2020, the ISN represented the global kidney health community at the 73rd session of the WHO’s World Health Assembly (WHA) in Geneva. At this historic WHA, which took place virtually due to COVID-19-related restrictions, delegates adopted a landmark resolution to press for solidarity in addressing the pandemic. The resolution calls for a joint and intensified effort...